Dario Expands Obesity Care with AI-Powered GLP-1 Program
NEW YORK, July 30, 2026 DarioHealth Corp. has unveiled its Integrated GLP-1 Program, a comprehensive healthcare solution that combines...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
NEW YORK, July 30, 2026 DarioHealth Corp. has unveiled its Integrated GLP-1 Program, a comprehensive healthcare solution that combines...
PROVIDENCE, Rhode Island, July 6, 2026 Nabsys 2.0, LLC, a pioneer in electronic genome mapping (EGM) technology, has appointed...
COLLEGE STATION, Texas, July 6, 2026 Matica Biotechnology, Inc. (Matica Bio) has entered into a strategic partnership with VaxDome...
NEW YORK, July 6, 2026 DarioHealth Corp. has announced a significant expansion of its digital health platform through a...
BAGSVÆRD, Denmark, June 11, 2026 Novo Nordisk announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has...
BAGSVÆRD, Denmark, June 3, 2026 Novo Nordisk has announced the launch of Wegovy® pill (semaglutide tablets) in the United...
TEL AVIV, Israel & PARIS, May 21, 2026 Teva Pharmaceuticals and Medincell have announced that the European Medicines Agency...
MUMBAI, India and NAPLES, Fla., May 18, 2026 Lupin Limited has announced that it has received tentative approval from...
BASEL, Switzerland, May 15, 2026 Sandoz has announced that the European Commission (EC) granted marketing authorization for two biosimilar...
MILWAUKEE, Feb. 15, 2026 — New research presented by the American Academy of Allergy, Asthma & Immunology (AAAAI) reveals...
